MIT Therapy - Extract Shot [15mL] (Dave's Brew) 12ct Display
MIT Therapy - Dave's Brew Extract Shot is a fast-acting, nano-emulsified kratom extract shot engineered for smooth, balanced effects — clean take-off, steady cruise, and gentle landing. Each 15mL bottle packs 100mg of Mitragynine alongside a 1,425mg proprietary nootropic blend and 125mg of caffeine per serving, making it a go-to shot for energy, focus, and mood support. Sold as a 12-bottle countertop display, ready for shelf placement.
Product Highlights
- 100mg Mitragynine per bottle — premium nano-emulsified kratom extract
- Proprietary nootropic blend (1,425mg) — supports cognitive lift and focus
- 125mg caffeine per serving — clean, steady energy
- Nano-emulsion technology — faster absorption, more consistent effects
- 12-count display box — merchandising-ready
- Ready to drink — no mixing required
- <0.03% 7-Hydroxymitragynine — naturally occurring trace amount
Specifications
- Active Ingredient: Mitragyna Speciosa (Kratom) Extract
- Mitragynine Content: 100mg per bottle
- Serving Size: 1/3 Bottle (5mL)
- Servings per Bottle: 3 (approximately)
- Bottle Volume: 15mL
- Display Pack: 12 bottles per display
- Per Serving: 33mg Mitragyna Speciosa, 125mg caffeine, 1,425mg proprietary blend
- Format: Liquid extract shot (nano-emulsified)
Suggested Use
Shake well before use. Start with one 5mL serving (1/3 of the bottle) and wait at least 6 hours before considering an additional serving. Do not exceed one bottle within a 24-hour period. Refrigerate after opening for best freshness.
Quality Assurance
MIT Therapy manufactures every batch in a GMP-certified facility with lab-tested potency and purity. Nano-emulsified for rapid and reliable delivery, sealed and tamper-evident for customer confidence.
For adult use only (21+). Not for sale to minors, pregnant or nursing women. Do not operate heavy machinery after use. Keep out of reach of children and pets. Kratom may be habit-forming. Not available for sale in AL, AR, IN, RI, WI, and restricted counties in FL, CA, IL, MS, and LA. These statements have not been evaluated by the FDA.